Zacks Investment Research · 13 Aug 2026negative
QXO, Inc. reported Q2 earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share in the same quarter a year ago.
Why it matters — QXO watchers would care because the company fell short of analyst expectations and reported lower earnings than in the prior-year quarter.
Business Wire · 13 Aug 2026neutral
QXO, Inc. reported financial results for the second quarter of 2026. For the three months ended June 30, 2026, basic and diluted loss per common share was $(0.14), while Adjusted Diluted Earnings per Common Share, a non-GAAP measure, was $0.08. The reported results include the legacy Kodiak Building Partners operational results.
Why it matters — QXO watchers would care because these results provide the latest data on the company's financial performance, including its adjusted earnings measure and the inclusion of the legacy Kodiak Building Partners operations.
The Motley Fool · 9 Aug 2026negative
QXO, Inc. closed on its largest-ever acquisition, and the acquired company's shareholders overwhelmingly chose cash instead of QXO shares, which the report says may signal a lack of confidence in the stock. As a result, QXO shares fell over 20% in July.
Why it matters — A QXO watcher would care because the acquiree's shareholders' preference for cash over QXO shares may indicate weak confidence in the company's stock, coinciding with a sharp share-price decline in July.
Zacks Investment Research · 6 Aug 2026negative
Zacks Investment Research published an earnings preview for QXO, Inc. (QXO) ahead of its upcoming Q2 report. The preview indicates the company lacks the combination of ingredients typically needed for a likely earnings beat, with Q2 earnings expected to decline.
Why it matters — QXO watchers would care because the preview sets expectations for a lower Q2 earnings result, signaling a potentially disappointing report.
Seeking Alpha · 6 Aug 2026neutral
Seeking Alpha featured top picks from 33 new analysts it welcomed in July 2026, highlighting companies including SELLAS Life Sciences, Chevron, B2Gold, Amazon, and QXO, each with detailed investment theses emphasizing asymmetric opportunities, event-driven catalysts, balance sheet strength, and sector-specific risks.
Why it matters — QXO watchers may want to see how a newly featured analyst frames an investment thesis for the company.